Skip to content
Screener

Harmony Biosciences Holdings, Inc. HRMY Short-Term Investments

Short-Term Investments at other companies

Alkermes logo
AlkermesALKS
$145.05M-70.7%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$187.89M+128%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$571.49M+12.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$76.25M-50.8%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$283.79M+97.3%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$344.6M+45.7%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$2.24B+11.7%
Enterprise value$1.81B+11.2%
P/E15.4×+4.3×
P/S2.5×-0.1×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:16 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056720
Line itemMarch 31, 2026December 31, 2025
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$589,398$752,502
Investments, short-term51,52022,838
Trade receivables, net108,22296,787
Inventory, net5,2815,357
Prepaid expenses16,80116,014
Other current assets7,59513,516

Item 1. Financial Statements

FAQ

What is Harmony Biosciences Holdings, Inc.'s short-term investments?
Harmony Biosciences Holdings, Inc. (HRMY) reported short-term investments of $51.52M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s short-term investments changed year-over-year?
Harmony Biosciences Holdings, Inc.'s short-term investments increased by 186.9% year-over-year, from $17.96M to $51.52M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s short-term investments?
Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s short-term investments has grown at a -34.0% compound annual growth rate (CAGR), from $79.33M to $22.84M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Ask your AI about Harmony Biosciences Holdings, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude